A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction

BACKGROUND: Tenofovir alafenamide (TAF) is associated with less renal and bone toxicity compared with tenofovir disoproxil (TDF). TAF's recent FDA approval has spurred HIV providers to consider switching antiretroviral therapy (ART) regimens containing TDF to TAF to minimize long term risks. Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sarah S., Havens, Joshua P., Sayles, Harlan R., O’Neill, Jennifer L., Podany, Anthony T., Swindells, Susan, Scarsi, Kimberly K., Bares, Sara H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035459/
https://www.ncbi.nlm.nih.gov/pubmed/29980192
http://dx.doi.org/10.1186/s12879-018-3226-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035459/
https://www.ncbi.nlm.nih.gov/pubmed/29980192
http://dx.doi.org/10.1186/s12879-018-3226-2

Ejemplares similares